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The efficacy of imipenem alone or in association with gcntamicin against
Staphylococcus aureus experimental endocarditis was compared to the efficacy of
cloxacillin alone or in association with gentamicin. Parenteral treatment was started
24 h after intravenous bacterial challenge of rats with catheter-induced aortic valve
vegetations. The cloxacillin MIC and MBC for Staph. aureus were 0-125 and
32 mg/1 and the imipenem MIC and MBC 0008 and 8 mg/1, respectively. In-vitro
killing curves showed a synergistic effect between cloxacillin and gentamicin, and an
additive effect between imipenem and gentamicin. Only large doses of cloxacillin
(400 mg/kg tid) (producing serum levels above those obtained after intravenous
injection of 2 g in man) achieved results comparable to those of imipenem 80 mg/kg
tid (producing serum levels similar to those obtained after an intravenous dose of
750 mg in man) in reducing the bacterial numbers in vegetations after 3 and 5 days
of treatment. There was a significantly greater reduction of bacterial numbers in
vegetations after treatment with the association of cloxacillin and gentamicin than
with cloxacillin alone. In contrast, the addition of gentamicin to imipenem did not
improve significantly the results of treatment with imipenem alone, but imipenem
alone was as good as the combination cloxacillin and gentamicin after 5 days of
treatment. We conclude that imipenem is a highly bactericidal drug in this animal
model, worth considering for clinical trials in the treatment of Staph. aureus
infections.
Introduction
Imipenem is a stable modified form of thienamycin, a /Mactam antibiotic of the
carbapenem class. Its spectrum of action is unusually broad, with important in-vitro
activity against the majority of bacteria often creating therapeutic problems, such as
Bacteroides fragilis, carbenicillin-resistant Pseudomonas aeruginosa, Streptococcus
faecalis, methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis
(Cherubin et al. 1981; Kesado, Hashizume & Ashai, 1980; Kesado et al., 1982;
Livingston, Elliott & Cobbs, 1981; Michael, Alford & McGee, 1981; Thompson,
Fischer & Wenzel, 1982; Verbist & Verhaegen, 1981). Only a small incidence of cross-
resistance to penicillins and cephalosporins has been demonstrated with imipenem. In
addition to its potential application in the treatment of infections due to multi*resistant
organisms, imipenem may have a place in the empirical treatment of infections which
at present require the association of 2 or more antibiotics.
The high in-vitro activity of imipenem against Staph. aureus and Staph.
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epidermidis, including some methicillin-resistant strains (Cherubin et al., 1981;
Livingston et al, 1981; Thompson et al., 1982) justified in-vivo studies of this drug in
infections caused by these organisms. We selected a model of left-sided Staph. aureus
endocarditis because it offers several advantages to test the efficacy of antibiotics.
Firstly, it mimics human endocarditis, in that sterile valvular aortic vegetations
(induced by the presence of a polyethylene catheter) are infected by the intravenous
inoculation of bacteria, the ensuing endocarditis displaying several of the
characteristics of human disease. Secondly, since in endocardial infections the
polymorphonuclear leukocytes have limited access to the bacteria embedded in the
valvular vegetations, the host defence mechanisms are of limited help in this type of
infection (Durack, Beeson & Petersdorf, 1973; Hook & Sande, 1974). Bacteriostatic
antibiotics have failed in the treatment of endocarditis (Walker et al, 1962), and one
must rely on the bactericidal activity of antibiotics to achieve cure (Carrizosa & Kaye,
1977; Hamburger et al., 1967). Left-sided Staph. aureus endocarditis is therefore a
suitable test of the killing power of a new compound against one of the most virulent
organisms. Thirdly, the treatment of Staph. aureus endocarditis has been extensively
studied in animals, making possible the comparison of the efficacy of new drugs with
that of reference antibiotics (Hamburger et al., 1967; Miller, Wexler & Steigbigel,
1978; Sande & Johnson, 1975; Sande & Courtney, 1976).
The present study was undertaken to determine the in-vivo efficacy of imipenem in
the rat model of Staph. aureus endocarditis, compared to that of cloxacillin. In
addition, these 2 antibiotics were given either alone or in association with gentamicin
in order to detect any possible synergism or antagonism.
Material and methods
Micro-organism
A strain of Staph. aureus isolated from a patient with bacterial endocarditis was used.
Minimal inhibitory and bactericidal concentrations (MIC and MBC) of cloxacillin,
gentamicin and imipenem were determined by broth dilution tests (Washington &
Sutter, 1980) with an inoculum of 5 x 10s organisms from an overnight culture. To
determine the MBC, 01 ml of an undiluted sample from each dilution of antibiotic
showing no turbidity after both 24 h and 48 h of incubation, as well as 01 ml of 10-fold
and 100-fold broth dilutions, were plated on penicillinase-containing blood agar. 10-
fold and 100-fold dilution of the antibiotic-containing broth avoids carry-over of
antibiotic, a phenomenon that can give falsely low MBCs. After incubation of the
blood agar plates for 48 h, the number of colonies on each plate was counted, and the
MBC determined as the lowest dilution of antibiotic which showed a 99-9% killing of
the original inoculum.
Killing curves with various concentrations and combinations of cloxaciUin,
gentamicin and imipenem were performed in trypticase soya broth (Difco
Laboratories, Detroit, Mich.) using an inoculum of 5 x 10s to 106 cfu/ml of an
overnight culture of Staph. aureus.
Production of endocarditis
Sterile vegetations were produced in female Wistar rats (180 to 200 g) by a
modification of a method already described (Heralef, Glauser & Freedman, 1982).
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Briefly, a polyethylene catheter (PP 10, Portex Ltd, Hythe, Kent, England) was
inserted across the aortic valve through the right carotid artery and secured with a silk
ligature. Twenty-four hours after catheterization, rats were injected in the tail vein with
0-5 ml of saline containing 10s cfu of Staph. aureus. The catheter was left in place
thoughout the experiments.
Evaluation of infection
Rats were killed at different intervals, at least 8 h after the last antibiotic
administration, when no antibiotic activity was detectable in blood. One ml of blood
was drawn from the inferior vena cava, plated on blood agar and incubated for colony
counts. Aortic vegetations, spleen and left kidney were excised, weighed, homogenized
in 1 ml of saline and serially diluted and plated. Plates were counted after 24 h of
incubation at 37°C. This method permitted the detection of 102 cfu/g of organ.
Treatment of Staph. aureus endocarditis with various antibiotic regimens
Treatment with antibiotics was started 24 h after injection of 105 cfu of Staph. aureus
in the tail vein of the rats. In each experiment, control rats were killed at the time of
starting treatment to determine the incidence and magnitude of valvular infection and
of positive blood cultures. In the treatment groups, the rats were killed after 3, 5 and
10 days of treatment.
Imipenem (Merck Sharp and Dohme Research Laboratories, Rahway, New Jersey)
(without cilastatin) was reconstituted in a phosphate buffer solution pH 7.2 and
injected subcutaneously at doses of 30 and 80 mg/kg tid. Cloxacillin (Beecham
Research Laboratories, Brentford, England) was reconstituted with sterile water and
injected subcutaneously at doses of 50 and 400 mg/kg tid. Gentamicin (Schering
Corporation, Kenilworth, New Jersey) was diluted in water and injected intra-
muscularly at doses of 4 mg/kg tid. Control rats were injected subcutaneously with
saline.
Antibiotic serum levels
Serum levels of cloxacillin, gentamicin and imipenem at various intervals after one
injection were determined by the agar diffusion technique (Sabath & Anhalt, 1980).
Statistical evaluation
The Chi-square test with Yates' correction and the unpaired Student's /-test were used
for statistical comparisons.
Results
Determination of MIC and MBC for Staph. aureus
The MIC and MBC for the strain of Staph. aureus tested were respectively 0-125 and
32mg/l for cloxacillin, 0-125 and 2mg/l for gentamicin and 0008 and 8 mg/1 for
imipenem. According to Sabath et al. (1977), tolerance to antibiotics is defined as a
MBC/MIC ratio of 32 or more. Thus, the strain of Staph. aureus used in these
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experiments was tolerant to both cloxacillin and imipenem. We chose a tolerant strain
because using our technique of MBC determination which reduces the antibiotic carry-
over effect, we have found that the majority of Staph. aureus strains isolated from
blood cultures in our hospital and tested in this way were characterized by MBC/MIC
ratios of >32 (for cloxacillin, this was seen in 21 out of 24 strains, and for imipenem in
21 out of 23 strains collected in 1982).
Bacterial killing of Staph. aureus by cloxacillin and imipenem, alone and in combination
with gentamicin
The Staph. aureus timed kill curves determined with concentrations of antibiotics
between the MIC and MBC demonstrated synergism between cloxacillin and
gentamicin (Figure 1). In contrast, only an additive effect could be seen with the
association of imipenem and gentamicin (Figure 1).
Serum levels of antibiotics (Figure 2)
The levels obtained in rats after subcutaneous injection of 30 and 80mg/kg of
imipenem were comparable to levels obtained in men weighing 70 kg after intravenous
injection of 250 or 750 mg, respectively (Merck Sharp and Dohme, Rahway, USA,
unpublished data). The levels obtained in rats after the subcutaneous injection of
cloxacillin 50 mg/kg were comparable to levels obtained after intravenous injection of
0-5 g in men, whereas levels obtained after 400 mg/kg in rats were above levels
obtained after 2 g in men.
Animal studies
Severity of infection at the start of treatment. Thirty-nine rats were killed 24 h after
bacterial inoculation, at the time the various treatments were started. Valvular
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Figure 1. Staph. aureus timed kill curves with cloxacillin 0-5 mg/1 (CLOX 0-5) and imipenem 0-032 mg/1
(MK 0-032), alone and in combination with gentamicin 0-25 mg/1 (GENT 0-25).
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Figure 2. Rat serum levels after subcutaneous injection of cloxacillin 50 (CLOXA 50) and 400 mg/kg
(CLOX 400), of imipenem 30 (MK30) and 80 mg/kg (MK80), and after intramuscular injection of
gentamicin 4 mg/kg (GENT 4). Each point represents the mean ± s.D. of values in 3 to 5 rats.
vegetations were infected in all the animals and blood cultures were positive in 94%
(37 out of 39 rats). All of the spleens and 38 of 39 left kidneys displayed severe Staph.
aureus infection. The severity of valvular infection, expressed as colony forming units
of Staph. aureus/g of vegetations is reported in Figure 3 (control group).
Evolution of infection in control rats. Starting 24 h after bacterial inoculation (day 0),
16 control animals were injected with normal saline tid. The cumulative mortality was
63% (10 out of 16 rats) on day 1, 88% (14 out of 16) on day 2 and 100% on day 3. All
the dead animals had generalized infection as revealed by the cultures of blood, spleen,
kidney and aortic vegetations.
Effect of the 3-day treatment regimen (Figure 3). In the group treated with cloxacillin
50 mg/kg tid, the mortality was significantly reduced from 100% in control rats
receiving saline to 13% in rats receiving cloxacillin (2 out of 15 rats died) (x2 = 20-45,
/><10"5). However, the 50 mg/kg dose of cloxacillin did not diminish the bacterial
counts recovered upon cultures from the valvular vegetations when compared to
bacterial numbers recovered in rats killed at the beginning of treatment.
Furthermore, all rats killed after treatment with cloxacillin 50 mg/kg tid displayed
Staph. aureus positive blood cultures, as well as positive spleen and kidney cultures.
In contrast, every other treatment regimen given for 3 days significantly reduced the
valvular bacterial counts when compared to that in controls. Among the rats receiving
cloxacillin or imipenem combined with gentamicin, only the combination of
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Figure 3. Effect of 3 and 5 days' treatment regimens on quantitative cultures of aortic valve
vegetations. Control rats were killed 24 b after intravenous challenge with Staph. aureus. at the time of
starting treatments. Each point represents a rat CLOX SO and CLOX 400: treatment with cloxacillin SO and
400 mg/kg tid sq. Im 30 and im 80: treatment with imipenem 30 and 80 mg/kg tid sq. GENTA: treatment
with gentamicin 4 mg/kg tid im. The dashes represent the mean ± S.E.M. Statistical comparisons were done
using the unpaired Student's (-test.
gentamicin with cloxacillin 400 mg/kg tid showed a significant reduction in the
bacterial numbers when compared to the effect of the /Mactam antibiotics alone.
Effect of the 5 day treatment regimen (Figure 3). As in the 3 day treatment regimen,
the rats treated for 5 days with cloxacillin 50 mg/kg tid did not show a reduction in the
number of cfu/g of vegetations when compared to that observed at the beginning of
treatment. Blood, spleen and left kidney cultures grew Staph. aureus in all animals.
Only the mortality was reduced (26% versus 100%) (j2 = 15, 12, P< 10"*). Therefore,
this dose of cloxacillin allowed the rats to survive, but did not cause any regression of
the infection.
In contrast, every other 5-day treatment regimen achieved a significant reduction in
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bacterial numbers when compared to controls. lmipenem 80 mg/kg tid alone and
combined with gentamicin, and cloxacillin 400 mg/kg tid combined with gentamicin,
were the treatment regimens which showed the greatest reduction in valvular infection,
aoxacillin 400 mg/kg tid alone was significantly less effective than the combination of
cloxacillin 400 mg/kg tid with gentamicin (an observation correlating with in-vitro
synergism between cloxacillin and gentamicin), while the addition of gentamicin to
imipenem treatment did not improve significantly the effect of imipenem alone
(although a trend toward increased efficacy was observed).
Effect of the 10-day treatment regimen. The 4 treatment schedules tested (cloxacillin
400 mg/kg tid alone and in combination with gentamicin, imipenem 30 mg/kg tid alone
and in combination with gentamicin) cured cardiac infection in all of the animals
studied.
Discussion
In the endocarditis experiments reported here, the catheter which initiates the sterile
aortic vegetations was left in place throughout the entire period of observation. Under
these conditions, the evolution of Staph. aureus infection was particularly severe since
all animals died from infection in less than 4 days in the absence of antibiotic
treatment. The natural history of this model infection provided therefore a stringent
test of antibiotic efficacy.
The administration of cloxacillin 50 mg/kg produced serum levels greater than the
MIC for the infecting strain for approximately 90min after injection, but a level
reaching the MBC was never achieved. Using this dosage administered 3 times per day,
the treatment was unable to reduce Staph. aureus valvular infection, nor to eradicate
the micro-organism from the blood. This confirms previous observations, which
established the necessity of bactericidal antibiotic to cure endocarditis (Carrizosa &
Kaye, 1977; HamburgeT et al., 1967).
Studies using Staph. aureus endocarditis in rabbits have shown that penicillinase-
resistant penicillins associated with an aminoglycoside bring about a more rapid
eradication of bacteria than the /Mactam alone, provided the association was
synergistic in vitro. Aminoglycosides antibiotics administered alone were ineffective
(Michael et al., 1981; Sande & Johnson, 1975; Sande & Courtney, 1976). These
observations were confirmed in our rat model, in that the association of cloxacillin
with gentamicin, synergistic in vitro, was shown to have increased efficacy in rats after
both 3 and 5 days of treatment, when compared to the efficacy of cloxacillin alone.
This advantage, however, was not apparent after 10 days of treatment, because the
vegetations were sterile in both the cloxacillin alone and the cloxacillin plus gentamicin
treatment groups.
In contrast to the cloxacillin treatment regimens, the addition of gentamicin to
imipenem did not significantly improve the therapeutic effect of imipenem alone. This
could be related to the absence of an in-vitro synergistic effect observed upon the
addition of gentamicin to imipenem. Since a similar absence of synergism between
imipenem and gentamicin has been observed with other strains of Staph. aureus and
other bacteria (Zinner & KJastersky, 1982), one must rely on the bactericidal effect of
imipenem alone for the treatment of Staph. aureus infections. Nevertheless imipenem
alone in our experimental model provided after 5 days of treatment as great an
antibacterial effect as the synergistic combination of high doses of cloxacillin plus
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gentamicin. This response to infection was achieved with doses of imipenem producing
serum levels in rats easily obtainable in humans, while the doses of cloxacillin
necessary for similar results produced in rats serum levels higher than that usually
achieved in humans.
In conclusion, in this model of experimentally-produced Staph. aureus endocarditis
in rats, imipenem has been shown to be highly bactericidal, as bactericidal as the
synergistic combination of high doses of cloxacillin plus gentamicin after 5 days of
treatment. These results warrant further clinical studies to evaluate the usefulness of
imipenem in Staph. aureus infections in man.
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